Retinoblastoma protein-interacting zinc finger 1 (RIZ1) regulates the proliferation of monocytic leukemia cells via activation of p53

Cancer Investigation

Volumn 28, Issue 8, 2010, Pages 806-812

  Shadat, Noman Mohammod Abu ^a   Koide, Naoki ^a   Khuda, Imtiaz I E ^a   Dagvadorj, Jargalsaikhan ^a   Tumurkhuu, Gantsetseg ^a   Naiki, Yoshikazu ^a   Komatsu, Takayuki ^a   Yoshida, Tomoaki ^a   Yokochi, Takashi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Leukemias; Signal transduction; Tumor suppressors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; PROTEIN P53; PROTEIN RIZ1; RETINOBLASTOMA PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; DNA BINDING PROTEIN; HISTONE LYSINE METHYLTRANSFERASE; NUCLEAR PROTEIN; PRDM2 PROTEIN, HUMAN; PRIMER DNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LEUKEMIA CELL; MONOCYTIC LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CELL DIVISION; DNA METHYLATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HOMEOSTASIS; METABOLISM; MYELOID LEUKEMIA; NEOPLASM; PATHOLOGY;

ANIMALS; CELL DIVISION; DNA METHYLATION; DNA PRIMERS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HISTONE-LYSINE N-METHYLTRANSFERASE; HOMEOSTASIS; HUMANS; LEUKEMIA, MYELOID; MICE; NEOPLASMS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77956642980     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2010.494323     Document Type: Article

References (43)

1. Liu, L.; Shao, G.; Steele-Perkins, G.; Huang, S. The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter. J Biol Chem 1997, 272(5) 2984-2991.
2. He, L.; Yu, J.X.; Liu, L.; Buyse, I.M.; Wang, M.S.; Yang, Q.C.; Nakagawara, A.; Brodeur, G.M.; Shi, Y.E.; Huang, S. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res 1998, 58(19), 4238-4244.
3. Jiang, G.; Liu, L.; Buyse, I.M.; Simon, D.; Huang, S. Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int J Cancer 1999, 83(4), 541-546.
4. Chadwick, R.B.; Jiang, G.L.; Bennington, G.A.; Yuan, B.; Johnson, C.K.; Stevens, M.W.; Niemann, T.H.; Peltomaki, P.; Huang, S.; de la Chapelle, A. Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc Natl Acad Sci USA 2000, 97(6), 2662-2667.
5. Sasaki, O.; Meguro, K.; Tohmiya, Y.; Funato, T.; Shibahara, S.; Sasaki, T. Altered expression of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukaemia. Br J Haematol 2002, 119(4), 940-948.
6. Poetsch, M.; Dittberner, T.; Woenckhaus, C. Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36. Oncogene 2002, 21(19), 3038-3042.
7. Du, Y.; Jenkins, N.A.; Copeland, N.G. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 2005, 106(12), 3932-3939.
8. Steele-Perkins, G.; Fang, W.; Yang, X.H.; Van Gele, M.; Carling, T.; Gu, J.; Buyse, I.M.; Fletcher, J.A.; Liu, J.; Bronson, R.; Chadwick, R.B.; de la Chapelle, A.; Zhang, X.; Speleman, F.; Huang, S. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein- methyltransferase super family. Genes Dev 2001, 15(17), 2250-2262.
9. Du, Y.; Carling, T.; Fang, W.; Piao, Z.; Sheu, J.C.; Huang, S. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res 2001, 61(22), 8094-8099.
10. Oshimo, Y.; Oue, N.; Mitani, Y.; Nakayama, H.; Kitadai, Y.; Yoshida, K.; Chayama, K.; Yasui,W. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma. Int J Cancer 2004, 110(2), 212-218. (Pubitemid 38580393)
11. Gazzerro, P.; Abbondanza, C.; DArcangelo, A.; Rossi, M.; Medici, N.; Moncharmont, B.; Puca, G.A. Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation. Exp Cell Res 2006, 312(3), 340-349.
12. Pastural, E.; Takahashi, N.; Dong, W.F.; Bainbridge, M.; Hull, A.; Pearson, D.; Huang, S.; Lowsky, R.; DeCoteau, J.F.; Geyer, C.R. RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines. Oncogene 2007, 26(11), 1586-1594.
13. Meloni, F. Tumor necrosis factor alpha. Biological aspects. G Ital Chemioter 1989, 36(1-3), 29-37.
14. Dinarello, C.A.; Cannon, J.G.; Wolff, S.M.; Bernheim, H.A.; Beutler, B.; Cerami, A.; Figari, I.S.; Palladino, M.A., Jr.; OConnor, J.V. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986, 163(6), 1433-1450.
15. Beutler, B.; Cerami, A. Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation. Immunol Res 1986, 5(4), 281-293.
16. Old, L.J. Tumor necrosis factor (TNF). Science 1985, 230(4726), 630-632.
17. Sugarman, B.J.; Aggarwal, B.B.; Hass, P.E.; Figari, I.S.; Palladino, M.A., Jr.; Shepard, H.M. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 1985, 230(4728), 943-945.
18. Schweigerer, L.; Malerstein, B.; Gospodarowicz, D. Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. Biochem Biophys Res Commun 1987, 143(3), 997-1004.
19. Rusten, L.S.; Smeland, E.B.; Jacobsen, F.W.; Lien, E.; Lesslauer, W.; Loetscher, H.; Dubois, C.M.; Jacobsen, S.E. Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors. J Clin Invest 1994, 94(1), 165-172.
20. Zhang, Y.; Harada, A.; Bluethmann, H.; Wang, J.B.; Nakao, S.; Mukaida, N.; Matsushima, K. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro. Blood 1995, 86(8), 2930-2937.
21. Caux, C.; Saeland, S.; Favre, C.; Duvert, V.; Mannoni, P.; Banchereau, J. Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells. Blood 1990, 75(12), 2292-2298.
22. Widera, D.; Mikenberg, I.; Elvers, M.; Kaltschmidt, C.; Kaltschmidt, B. Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappa B signaling. BMC Neurosci 2006, 7(64), 1-18.
23. Tsao, M.S.; Munzer, J.S.; Lee, D.; Phillips, N.C. The comparative effects of tumor necrosis factor on tumor cells growing anchorage dependently and independently. J Biol Response Mod 1989, 8(3), 297-304.
24. Van Der Veen, A.H.; ten Hagen, T.L.; de Wilt, J.H.; van Ijken, M.G.; Eggermont, A.M. An overview on the use of TNF-alpha: our experience with regional administration and developments towards new opportunities for systemic application. Anticancer Res 2000, 20(5B) 3467-3474.
25. Ozes, O.N.; Mayo, L.D.; Gustin, J.A.; Pfeffer, S.R.; Pfeffer, L.M.; Donner, D.B. NF-kappa B activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999, 401(6748) 82-85.
26. Wati, S.; Li, P.; Burrell, C.J.; Carr, J.M. Dengue Virus (DV) replication in monocyte-derived macrophages is not affected by tumor necrosis factor alpha (TNF-α), and dv infection induces altered responsiveness to TNF-α stimulation. J Virol 2007, 81(18), 10161-10171.
27. Hassan, F.; Islam, S.; Tumurkhuu, G.; Naiki, Y.; Koide, N.; Mori, I.; Yoshida, T.; Yokochi, T. Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide. BMC Cancer 2006, 6(281), 1-8.
28. Chakravortty, D.; Kato, Y.; Sugiyama, T.; Koide, N.; Mu, M.M.; Yoshida, T.; Yokochi, T. The inhibitory action of sodium arsenite on lipopolysaccharide- induced nitric oxide production in RAW 267.4 macrophage cells: a role of Raf-1 in lipopolysaccharide signaling. J Immunol 2001, 166(3), 2011-2017.
29. Tsunoda, N.; Kokuryo, T.; Oda, K.; Senga, T.; Yokoyama, Y.; Nagino, M.; Nimura, Y.; Hamaguchi, M. Nek2 as a novel molecular target for the treatment of breast carcinoma. Cancer Sci 2009, 100(1), 111-116.
30. Sohmura, Y.; Nakata, K.; Yoshida, H.; Kashimoto, S.; Matsui, Y.; Furuichi, H. Recombinant human tumor necrosis factor-II. Antitumor effect on murine and human tumors transplanted in mice. Int J Immunopharmacol 1986, 8(3), 357-368. (Pubitemid 16097761)
31. Murase, T.; Hotta, T.; Saito, H.; Ohno, R. Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells. Blood 1987, 69(2), 467-472.
32. Hehner, S.P.; Hofmann, T.G.; Dröge, W.; Schmitz, M.L. The anti-inflammatory sesquiterpene lactone parthenolide inhibits NFkappa B by targeting the I kappa B kinase complex. J Immunol 1999, 163(10), 5617-5623.
33. Vlahos, C.J.; Matter, W.F.; Hui, K.Y.; Brown, R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4- one (LY294002). J Biol Chem 1994, 269(7), 5241-5248.
34. Kim, K.C.; Geng, L.; Huang, S. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res 2003, 63(22), 7619-7623.
35. Komarov, P.G.; Komarova, E.A.; Kondratov, R.V.; Christov-Tselkov, K.; Coon, J.S.; Chernov, M.V.; Gudkov, A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999, 285(5434), 1733-1737.
36. Pardee, A.B. A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 1974, 71(4), 1286-1290.
37. Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100(1), 57-70.
38. Shin, S.I.; Freedman, V.H.; Risser, R.; Pollack, R. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci USA 1975, 72(11), 4435-4439.
39. Hasegawa, Y.; Matsubara, A.; Teishima, J.; Seki, M.; Mita, K.; Usui, T.; Oue, N.; Yasui, W. DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer. Cancer Sci 2007, 98(1), 32-36.
40. Salyer, J.L.; Bohnsack, J.F.; Knape, W.A.; Shigeoka, A.O.; Ashwood, E.R.; Hill, H.R. Mechanisms of tumor necrosis factor-alpha alteration of PMN adhesion and migration. Am J Pathol 1990, 136(4), 831-841.
41. Pastor, D.M.; Irby, R.B.; Poritz, L.S. Tumor necrosis factor alpha induces p53 upregulated modulator of apoptosis expression in colorectal cancer cell lines. Dis Colon Rectum 2010, 53(3), 257-263.
42. Haranaka, K.; Satomi, N.; Sakurai, A. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer 1984, 34(2), 263-267.
43. Manda, T.; Shimomura, K.; Mukumoto, S.; Kobayashi, K.; Mizota, T.; Hirai, O.; Matsumoto, S.; Oku, T.; Nishigaki, F.; Mori, J.; Kikuchi, H. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity. Cancer Res 1987, 47(14), 3707-3711.